Cargando…
Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes
There is a need for countermeasures to mitigate lethal acute radiation syndrome (ARS) and delayed effects of acute radiation exposure (DEARE). In WAG/RijCmcr rats, ARS occurs by 30-days following total body irradiation (TBI), and manifests as potentially lethal gastrointestinal (GI) and hematopoieti...
Autores principales: | Gasperetti, Tracy, Miller, Tessa, Gao, Feng, Narayanan, Jayashree, Jacobs, Elizabeth R., Szabo, Aniko, Cox, George N., Orschell, Christie M., Fish, Brian L., Medhora, Meetha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165380/ https://www.ncbi.nlm.nih.gov/pubmed/34079456 http://dx.doi.org/10.3389/fphar.2021.634477 |
Ejemplares similares
-
Corrigendum: Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes
por: Gasperetti, Tracy, et al.
Publicado: (2021) -
Radiation Increases Bioavailability of Lisinopril, a Mitigator of Radiation-Induced Toxicities
por: Medhora, Meetha, et al.
Publicado: (2021) -
Wound Trauma Exacerbates Acute, but not Delayed, Effects of Radiation in Rats: Mitigation by Lisinopril
por: Medhora, Meetha, et al.
Publicado: (2020) -
Biomarkers to Predict Lethal Radiation Injury to the Rat Lung
por: Medhora, Meetha, et al.
Publicado: (2023) -
Dose-modifying factor for captopril for mitigation of radiation injury to normal lung
por: Medhora, Meetha, et al.
Publicado: (2012)